The SRC-3 gene is amplified in 5–10% of breast cancers [4, 5], and the levels of the SRC-3 mRNA or protein are increased by ~ 60% in multiple different cohorts of patients with breast cancer [6, 7]. This evidence concerns the gene NCOA3 and breast carcinoma.